U.S. Hotel and Resort REITs Stock News

Why the latest earnings and buyback matter for Village Farms International (VFF) Village Farms International (NasdaqCM:VFF) has drawn fresh attention after reporting fourth quarter and full year 2025 results that show net income for both periods, alongside completion of a US$2.98 million share repurchase program. See our latest analysis for Village Farms International. Despite turning net income positive for both the quarter and full year and completing the US$2.98 million buyback, Village...

M&T Bank (NYSE:MTB) CEO releases an annual letter highlighting investments in technology and talent as key priorities. The letter links these investments to the bank’s recent performance and outlines how they fit into long term plans. Management stresses a sustained focus on digital capabilities, data, and workforce development in a choppy economic climate. M&T Bank is a regional banking group with a focus on traditional lending, deposits, and related financial services, and it operates in...

If you are wondering whether JFrog's current share price reflects its true worth, this breakdown will help you connect the recent numbers to what you are actually paying for the stock. At a last close of US$43.83, JFrog has returned 7.1% over the past week, while the 30 day and year to date returns of 15.2% and 26.4% respectively contrast with a 29.2% return over the past year and 127.7% over three years. Recent headlines have focused broadly on the software sector and investor interest in...

Wondering if Ascendis Pharma at around US$228.06 per share still offers value or if the easy gains are behind it? This article focuses squarely on what the current price might imply about future expectations. The stock has been volatile recently, with a 5.2% decline over the last week, a 5.4% gain over the past month, and returns of 6.9% year to date and 38.5% over the last year. These shifts can change how you think about both opportunity and risk. These moves sit against a backdrop of...

Earlier in March 2026, Samsara Inc. reported fourth-quarter revenue of US$444.3 million and full-year revenue of US$1.62 billion, turning a quarterly profit while nearly eliminating its annual net loss, and soon after filed a US$1.11 billion shelf registration for 34,842,934 Class A shares tied to employee stock programs. Around the same time, the company introduced new AI-driven coaching features for its fleet safety platform and secured a US$30.3 million arbitration award, changes that...

Textron’s Bell unit recently secured orders from South Africa’s National Transmission Company for seven Bell 407GX helicopters and from the Pasadena Police Department for two Bell 505 helicopters, all designated for utility and public safety missions. These contracts highlight how Textron is extending the reach of its helicopter portfolio into both international infrastructure work and specialized municipal law‑enforcement operations. Next, we’ll examine how these new helicopter orders,...

FTI Consulting (FCN) has been drawing attention after recent share price moves, with the stock last closing at US$163.42. Investors are weighing this performance against its earnings profile and multi segment advisory business. See our latest analysis for FTI Consulting. The recent 1 day share price return of 0.93% and 7 day share price return of 0.65% sit against a 90 day share price return of 7.52% and a 1 year total shareholder return of 1.90%. This suggests momentum has cooled after...

Eversept Partners has made a significant institutional investment in Avantor (NYSE:AVTR), increasing its ownership stake in the company. The move comes as Avantor presses ahead with its Revival program, which is aimed at responding to prolonged organic revenue declines and restructuring efforts. These ownership changes and internal initiatives are drawing fresh attention to Avantor's potential direction and risk profile. Avantor supplies products and services to the life sciences and...

Director Jack Bendheim has sold a significant amount of NasdaqGM:PAHC stock under a pre arranged trading plan. BFI Co., LLC has converted 100,000 shares of Phibro Animal Health Class B Common Stock into Class A Common Stock. The transactions affect insider holdings, voting rights, and the mix between Class A and Class B shares in the company’s capital structure. Phibro Animal Health, listed on NasdaqGM:PAHC, focuses on animal health and nutrition products that support livestock producers...

Wondering if HEICO at around US$292.21 is still offering value, or if the best days are already priced in? This article focuses squarely on what you are paying versus what you might be getting. The share price sits near US$292.21 after a 4.6% decline over the past week and 12.1% over the last month, yet the stock has returned 12.1% over 1 year, 74.6% over 3 years and 140.9% over 5 years. Recent coverage has focused on HEICO as a key aerospace and defense name, with investors watching how...

Teekay Tankers recently reported strong 2025 operational and financial results, highlighting a zero‑debt balance sheet and significant free cash flow supported by a robust spot tanker market shaped by geopolitical tensions and sanctions-related trade shifts. The company’s gradual fleet renewal, focused on selective vessel acquisitions and sales while benefiting from heightened demand for compliant tankers, underscores how sanctions on Russian, Iranian, and Venezuelan oil are structurally...

Earlier in March 2026, Citizens Financial Group received multiple analyst upgrades highlighting its loan growth, net interest margin expansion, and strong capital return, while simultaneously announcing new community and economic investment commitments in San Francisco, including US$250,000 for the San Francisco Downtown Development Corporation and US$500,000 for Main Street Launch. Together, these endorsements and local investments highlight Citizens’ attempt to pair national financial...

Nuvation Bio (NYSE:NUVB) presented nearly one additional year of follow up data from the TRUST-I and TRUST-II studies of IBTROZI (taletrectinib) at the AACR Annual Meeting 2026. The new data focus on long term efficacy and safety in ROS1 positive non small cell lung cancer, including both treatment naïve and previously treated patients. This update builds on IBTROZI's existing FDA approval and adds fresh clinical detail that has not been reflected in recent coverage of the company. Nuvation...

Cold Case Ice Cream is expanding into more than 1,000 Kroger banner stores across the US. The rollout brings a trend-focused premium ice cream brand to a wide range of Kroger owned banners. The move underscores Kroger's focus on differentiated product assortments in the grocery aisle. For investors watching NYSE:KR, this large scale rollout highlights how Kroger is using branded partnerships to keep its frozen aisle fresh and relevant. The company operates a broad network of supermarket...

ATI Inc. recently expanded its share repurchase program, with the board approving an additional US$500 million authorization that can be executed in the open market or through privately negotiated transactions without timing restrictions. This larger buyback pool, coming on top of prior repurchases that have already helped earnings per share grow faster than revenue, underscores management’s confidence in ATI’s long-term performance and capital return priorities. Next, we’ll examine how...

For investors wondering whether Micron Technology at US$461.69 is priced for perfection or still offers value, this article walks through what the numbers indicate about the stock. The share price performance has been strong, with returns of 14.5% over 7 days, 12.2% over 30 days, 46.4% year to date, 355.4% over 1 year, around 7x over 3 years, and 454.1% over 5 years. These moves can change how investors think about both upside and risk. These moves are playing out against a backdrop where...

Gold.com (GOLD) drew investor attention after appointing Juan Sartori to its Board of Directors and announcing the retirement of longtime director Beverley Lepine, a governance shift linked to experience in commodities and alternative assets. See our latest analysis for Gold.com. The Board change comes as Gold.com trades at a share price of $47.89, with a 46.45% 90 day share price return and a 71.11% 1 year total shareholder return. This suggests recent momentum has been strong despite a...

GeneDx Holdings (WGS) is back in focus after Ark Invest’s ETFs bought shares for seven straight trading days, alongside a new Niemann Pick disease type C genetic testing collaboration with Zevra Therapeutics. See our latest analysis for GeneDx Holdings. Despite Ark’s buying streak and the new Zevra partnership, GeneDx’s share price has been under pressure, with a 30 day share price return of a 16.25% decline and a year to date share price return of a 42.93% decline, while the three year total...

Recent performance snapshot EyePoint (EYPT) has drawn attention after mixed recent returns, with the share price up about 7% over the past month but showing a decline over the past 3 months and year to date. At a last close of US$13.90 and a market value of about US$1.12b, investors are weighing this performance against the company’s focus on retinal disease treatments and its developing product pipeline. See our latest analysis for EyePoint. That mix of a 7.42% 30 day share price return...

Madison Square Garden Entertainment (MSGE) has drawn fresh investor attention after appointing Allen Lo as Executive Vice President and Chief Legal Officer, a move that more closely connects the live entertainment group to deep technology and media legal expertise. See our latest analysis for Madison Square Garden Entertainment. The appointment of Allen Lo comes at a time when MSGE’s share price has pulled back in the short term. The 1 month share price return shows an 8% decline, but the 90...

In March 2026, Corvus Pharmaceuticals filed a universal shelf registration and expanded its at-the-market equity program with Jefferies to US$200 million, adding flexibility to issue common and preferred stock, debt, warrants and units to support ongoing operations. This expanded financing capacity sits alongside a sharp reduction in full-year 2025 net loss to US$15.28 million and continued clinical progress for lead candidate soquelitinib, together reshaping how investors may view the...

Recent performance snapshot Without a single clear news headline driving the move, Excelerate Energy (EE) has still drawn attention after a mixed run, with a roughly 17% decline over the past month alongside a gain of about 32% in the past 3 months. See our latest analysis for Excelerate Energy. At a share price of $34.65, Excelerate Energy’s recent 17% one-month share price decline contrasts with its 31.8% three-month share price return and 75% three-year total shareholder return, suggesting...

T. Rowe Price Group recently expanded its global retirement leadership team, appointing Jessica Sclafani as head of the Retirement Strategist team following Michael Davis’s planned retirement after a 34-year career in finance. Alongside these leadership moves, the firm is pushing further into active ETFs across emerging markets equities and cryptocurrencies, signaling a broader effort to broaden its product lineup and retirement-focused capabilities. We’ll now examine how T. Rowe Price’s...

Innodata recently reported past full-year 2025 organic revenue growth of 48%, reaching US$251.7 million, alongside a 22% year-over-year increase in fourth-quarter revenue, driven by accelerating demand for AI model training and deployment. Management highlighted that Innodata is moving beyond its traditional role as a data supplier to become a lifecycle partner for frontier AI initiatives, including agentic and physical AI projects. We’ll now explore how Innodata’s shift toward being a full...